{"url":"https://lda.senate.gov/api/v1/filings/d5d4bbbb-afee-454f-ad75-e69ad5c97499/","filing_uuid":"d5d4bbbb-afee-454f-ad75-e69ad5c97499","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2010,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d5d4bbbb-afee-454f-ad75-e69ad5c97499/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Daniel L. Spiegel, Senior of Counsel","dt_posted":"2010-10-20T10:24:36.417000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 Pennsylvania Avenue, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":11195,"url":"https://lda.senate.gov/api/v1/registrants/11195/","house_registrant_id":31827,"name":"COVINGTON & BURLING LLP","description":"Law firm","address_1":"850 10th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICHOLAS XENAKIS","contact_telephone":"+1 202-662-5846","dt_updated":"2026-07-29T10:42:26.460623-04:00"},"client":{"id":115144,"url":"https://lda.senate.gov/api/v1/clients/115144/","client_id":1004303,"name":"PFIZER (FORMERLY WYETH)","general_description":"Pharmaceutical products and vaccine manufacturer","client_government_entity":false,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-06-02"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Follow developments within the Executive Branch and at WHO and other multilateral organizations relating to international vaccine policy and financing mechanisms for access to advanced vaccines.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44089,"prefix":"ms","prefix_display":"MS.","first_name":"DANIEL","nickname":null,"middle_name":"L","last_name":"SPIEGEL","suffix":null,"suffix_display":null},"covered_position":"U.S. Ambassador to the UN (Geneva)","new":false},{"lobbyist":{"id":65340,"prefix":null,"prefix_display":null,"first_name":"C.","nickname":null,"middle_name":"ANNE","last_name":"PENCE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":39,"name":"State, Dept of (DOS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}